MMS Certification Cost 2026: Complete Pricing Breakdown

2026 Fee Overview: What AOBD Actually Charges

If you're mapping out the true cost of pursuing Subspecialty Certification in Mohs Micrographic Surgery (MMS) through the American Osteopathic Board of Dermatology (AOBD), the published fee schedule is straightforward on paper but easy to misjudge in practice. The certifying body is AOBD - not the American Osteopathic College of Dermatology, and not any other organization that happens to share the "MMS" acronym elsewhere in medicine. Every dollar figure below comes directly from AOBD's published applications and payment schedule for the initial Mohs Micrographic Surgery subspecialty certification exam.

For the 2026 cycle, the exam date is September 24, 2026, with a first application deadline of June 24, 2026 and a final application deadline of July 24, 2026. Those dates matter for cost planning because missing the final deadline doesn't just risk a delayed test date - it triggers an additional fee. For a full breakdown of the testing calendar itself, see MMS Exam Dates 2026: Testing Windows, Deadlines & Scheduling.

Initial Application Fee Breakdown

The USD 1,800 initial fee covers a single, unified application to sit for both parts of the exam: the written component (110 multiple-choice questions administered in two hours) and the practical component (evaluation of six submitted representative cases, with oral explanation offered if requested by the examiners). This is not two separate purchases - it is one fee for the full initial certification attempt.

What candidates frequently underestimate is that the practical component isn't optional scaffolding around the written exam - it's a gate. If you fail to submit your six practical cases correctly and on time, you are not permitted to sit the written component at all that cycle. That means the entire USD 1,800 investment hinges on getting case documentation right well before test day, not just studying content for the written portion.

Retake Costs: One-Component vs Both-Component

Retake pricing is where cost planning gets strategic. AOBD structures retakes into two tiers:

• One-component retake - USD 900: If you pass one component but not the other, you only pay to retake the component you failed.
• Both-component retake - USD 1,800: If you fail both components, or if your practical submission was disqualified outright, you pay the same amount as a first-time initial applicant.

Here's the detail that trips candidates up financially: a failed or incomplete practical attempt isn't a simple resubmission. A practical retake requires three new cases - you cannot reuse or patch your original six-case submission. That has real budget implications if your case flow is slow, since gathering three fresh qualifying cases takes clinical time you can't compress just because you already paid the retake fee.

Passing standard also matters here: the published passing standard for the written component is a scaled score of at least 500 on a 200-800 scale. Understanding exactly what that scaled score represents - and how far below or above it typical performance falls - helps you decide whether a borderline pass is worth banking on or whether extra preparation now is cheaper than a USD 900 retake later. See MMS Passing Score 2026: Exactly What You Need to Pass for the full explanation.

Late Fees and Deadline Mechanics

The 2026 cycle has two application deadlines: June 24, 2026 (first deadline) and July 24, 2026 (final deadline). Applications submitted between those two dates typically proceed without penalty, but anything submitted after the final deadline triggers the USD 540 late fee on top of whatever base fee applies to your situation (initial, one-component, or both-component).

That USD 540 is not trivial relative to the base fees - it represents roughly 30% of the initial application cost or more than half of a one-component retake fee. Candidates juggling fellowship schedules, clinical caseloads, or CLIA documentation gathering should treat June 24 as the real target date, not July 24. Building in a buffer avoids paying for administrative delay rather than exam content.

Hidden and Indirect Costs Candidates Overlook

The published AOBD fee schedule is only part of the real financial picture. Several indirect costs shape the total investment in earning this credential:

• Case documentation time: Compiling six representative cases (or three for a practical retake) with the level of detail AOBD requires takes administrative and clinical hours that have real opportunity cost, especially if you're doing this alongside a full clinical schedule.
• CLIA documentation: Eligibility requires CLIA documentation as part of the application, which may involve lab compliance verification steps depending on your practice setting.
• Study materials and practice questions: Preparing for 110 multiple-choice questions across eleven content areas typically means investing in structured review resources. A focused Mohs board review built around the actual coverage areas is far more cost-efficient than generic dermatology review material. Explore our practice test platform to see how targeted question banks map to AOBD's published topics.
• Fellowship or case-volume pathway costs: Depending on which eligibility route you take, you may be absorbing the cost of an accredited fellowship year or building toward the 500-case threshold over three years, both of which carry their own financial and time tradeoffs beyond the exam fee itself.
• Retake risk: Every dollar spent on inadequate preparation is a dollar that may need to be spent again at USD 900 or USD 1,800. Reviewing how difficult the exam actually is helps calibrate how much preparation investment is warranted; see How Hard Is the MMS Exam? Complete Difficulty Guide 2026.

How Your Eligibility Pathway Affects Total Cost

AOBD recognizes three eligibility routes toward the initial exam, and each carries a different cost structure long before you ever pay the USD 1,800 application fee:

For the full eligibility documentation checklist - including active AOBD certification, medical licensure, training and ethical documentation, and CLIA documentation - see MMS Requirements 2026: Eligibility, Prerequisites & How to Qualify.

Ten-Year Certification and OCC Maintenance Costs

Passing the initial exam isn't the end of the financial picture. Certification carries a ten-year term subject to Osteopathic Continuous Certification (OCC) requirements. Time-limited AOBD Diplomates need 60 CME credits during the 2025-2027 cycle, including 20 specialty-specific Category 1-A credits. Budgeting for ongoing CME - conference registration, journal-based credit programs, or specialty-specific coursework - should be part of your long-term cost planning, not an afterthought once you're already certified.

Whether the full ten-year cost picture - initial fee, potential retakes, case-gathering time, and OCC maintenance - pays off in practice is a question worth examining on its own. See Is the MMS Certification Worth It? Complete ROI Analysis 2026 for a fuller discussion, and MMS Salary Guide 2026: Complete Earnings Analysis for how the credential factors into hiring and compensation conversations with dermatology practices and Mohs surgery groups.

Budgeting Around the 2026 Application Timeline

Because fees escalate with delay (late fee) and with underperformance (retake fees), the smartest way to control total cost is to sequence your preparation against the actual calendar rather than treating study and payment as separate tracks.

For a broader preparation framework that ties study sequencing to the specific structure of this exam, see MMS Study Guide 2026: How to Pass on Your First Attempt. And if you want to gauge how your preparation compares to typical outcomes before committing to a testing date, MMS Pass Rate 2026: What the Data Shows puts the fee investment in context.

Frequently Asked Questions